Zum Inhalt springen
Black Friday — 30% OFFKostenloser Versand ab 99 € Bestellwert
  1. Startseite
  2. Kognitive Gesundheit und Nootropika
  3. Noopept (Omberacetam), (30mg/capsule), 60 Capsules
Kognitive Gesundheit

Noopept (Omberacetam), (30mg/capsule), 60 Capsules

Noopept (Omberacetam) is a synthetic dipeptide analog of the racetam family, known for its role in glutamatergic and cholinergic signaling pathways.

Darreichungsform: Noopept (Omberacetam), (30mg/capsule), 60 Capsules.

Mit KI erstellte illustrative Verpackung.

Ursprünglicher Preis war: 24,99 €Aktueller Preis ist: 17,49 €.

Derzeit nicht verfügbar in Deutschland

Berater fragen
Ein Berater meldet sich bei Ihnen, und die Partnerapotheke prüft, ob und wie es weitergehen kann. Ein gültiges Rezept oder eine Beurteilung durch einen zugelassenen Telemedizin-Dienst kann erforderlich sein.
  • Partnerapotheke
  • Persönliche Betreuung
  • Diskrete Lieferung
  • Darreichungsform
    Noopept (Omberacetam), (30mg/capsule), 60 Capsules

Versand und Lieferung

  • Versand in der Regel innerhalb von 24 Stunden nach Zahlungsbestätigung.
  • USPS Regular Shipping · 11,95 € · Ca. 3–5 Werktage
  • FedEx 2 Days Delivery · 28,99 € · Ca. 2 Werktage
  • FedEx Overnight Delivery · 40,99 € · Ca. 1 Werktag

Nur für die Laborforschung.

Nicht zur Anwendung bei Menschen oder Tieren.

Zusammensetzung und Produktdetails

Übersicht

Noopept (Omberacetam) is a synthetic dipeptide analog of the racetam family, known for its role in glutamatergic and cholinergic signaling pathways. It exhibits high affinity for AMPA and NMDA receptors, contributing to its involvement in synaptic transmission and neurochemical interactions.

This compound undergoes rapid hydrolysis into bioactive peptide fragments, facilitating its metabolic activity. Noopept is processed through hepatic oxidation and conjugation, with primary clearance occurring via renal excretion.

  • High Purity – 99% Purity Guaranteed
  • Independently Lab Tested
  • Research Grade Quality
  • For Laboratory Research Use Only

Eigenschaften

Noopept (ethyl 1-(phenylacetyl)-L-prolylglycinate) is a synthetic dipeptide-derived small molecule and prodrug of cycloprolylglycine (cPG), an endogenous cyclic peptide. Following biotransformation, it yields cycloprolylglycine, a metabolite investigated for its interactions with glutamatergic signaling systems, including AMPA- and NMDA receptor-associated pathways. Experimental studies have also examined Noopept’s interactions with peptide-mediated regulatory mechanisms, receptor-associated signaling networks, and molecular communication pathways involved in signal transduction. Additional investigations have explored its effects on protein interaction systems, transcriptional regulation processes, and small molecule–peptide pharmacology. Research applications include AMPA/NMDA receptor pharmacology, glutamatergic signaling investigation, prodrug metabolism studies, cycloprolylglycine-related research, and mechanistic evaluation of receptor-associated regulatory systems. Supplied in 30 mg capsules. Independently third-party HPLC-tested; COA available per batch.

Forschung

HPLC Noopept Caps (6739 / M26AYNoo)
September 11, 2026

HPLC Noopept Caps (6739)
August 7, 2026

Die Hilfsstoffe der Kapsel sind in den verfügbaren Produktunterlagen nicht angegeben.